Emergence of Orphan Drugs in the United States: a Quantitative Assessment of the First 25 Years (Nature Subscription Required)

Since the launch of the US Orphan Drug Act in 1983, more than 326 drugs have been approved to treat more than 200 rare diseases. The remarkable impact that this act over the past 25 years is discussed here.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail